Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?

Bertrand Tombal, Antonio Alcaraz, Nicholas James, Riccardo Valdagni, Jacques Irani

Research output: Contribution to journalArticle

Abstract

To identify criteria beyond Tumour-Node-Metastasis (TMN)-, prostate-specific antigen (PSA)- and Gleason score-based standard classifications to enhance the stratification of non-metastatic high-risk prostate cancer. A detailed search of the literature was performed using PubMed. The authors reviewed the literature and used a modified Delphi approach to identify relevant approaches to enhance standard classifications. Specific criteria for high-risk prostate cancer vary across guidelines and clinical trials, reflecting the differing perspectives concerning the definition of 'risk' between different specialities within the urology/radiation oncology community. In addition to the present classifications, evidence exists that the measure of cancer volume can provide additional prognostic value. More accurate imaging, especially multiparametric magnetic resonance imaging can also provide information concerning staging and cancer volume, and thus may assist in the identification of patients with high-risk prostate cancer. A refined definition of non-metastatic high-risk prostate cancer is proposed. Within this high-risk cohort, patients with multiple high-risk criteria are especially at risk of prostate cancer-specific mortality.

Original languageEnglish
Pages (from-to)189-199
Number of pages11
JournalBJU International
Volume113
Issue number2
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Prostatic Neoplasms
Hormones
Radiation Oncology
Neoplasm Grading
Neoplasm Staging
Urology
Prostate-Specific Antigen
PubMed
Neoplasms
Magnetic Resonance Imaging
Clinical Trials
Guidelines
Neoplasm Metastasis
Mortality

Keywords

  • high-risk prostate cancer
  • prostate cancer
  • risk stratification

ASJC Scopus subject areas

  • Urology

Cite this

Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer? / Tombal, Bertrand; Alcaraz, Antonio; James, Nicholas; Valdagni, Riccardo; Irani, Jacques.

In: BJU International, Vol. 113, No. 2, 02.2014, p. 189-199.

Research output: Contribution to journalArticle

Tombal, Bertrand ; Alcaraz, Antonio ; James, Nicholas ; Valdagni, Riccardo ; Irani, Jacques. / Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?. In: BJU International. 2014 ; Vol. 113, No. 2. pp. 189-199.
@article{4410de87939348de81406748c76a5e3f,
title = "Can we improve the definition of high-risk, hormone na{\"i}ve, non-metastatic prostate cancer?",
abstract = "To identify criteria beyond Tumour-Node-Metastasis (TMN)-, prostate-specific antigen (PSA)- and Gleason score-based standard classifications to enhance the stratification of non-metastatic high-risk prostate cancer. A detailed search of the literature was performed using PubMed. The authors reviewed the literature and used a modified Delphi approach to identify relevant approaches to enhance standard classifications. Specific criteria for high-risk prostate cancer vary across guidelines and clinical trials, reflecting the differing perspectives concerning the definition of 'risk' between different specialities within the urology/radiation oncology community. In addition to the present classifications, evidence exists that the measure of cancer volume can provide additional prognostic value. More accurate imaging, especially multiparametric magnetic resonance imaging can also provide information concerning staging and cancer volume, and thus may assist in the identification of patients with high-risk prostate cancer. A refined definition of non-metastatic high-risk prostate cancer is proposed. Within this high-risk cohort, patients with multiple high-risk criteria are especially at risk of prostate cancer-specific mortality.",
keywords = "high-risk prostate cancer, prostate cancer, risk stratification",
author = "Bertrand Tombal and Antonio Alcaraz and Nicholas James and Riccardo Valdagni and Jacques Irani",
year = "2014",
month = "2",
doi = "10.1111/bju.12469",
language = "English",
volume = "113",
pages = "189--199",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?

AU - Tombal, Bertrand

AU - Alcaraz, Antonio

AU - James, Nicholas

AU - Valdagni, Riccardo

AU - Irani, Jacques

PY - 2014/2

Y1 - 2014/2

N2 - To identify criteria beyond Tumour-Node-Metastasis (TMN)-, prostate-specific antigen (PSA)- and Gleason score-based standard classifications to enhance the stratification of non-metastatic high-risk prostate cancer. A detailed search of the literature was performed using PubMed. The authors reviewed the literature and used a modified Delphi approach to identify relevant approaches to enhance standard classifications. Specific criteria for high-risk prostate cancer vary across guidelines and clinical trials, reflecting the differing perspectives concerning the definition of 'risk' between different specialities within the urology/radiation oncology community. In addition to the present classifications, evidence exists that the measure of cancer volume can provide additional prognostic value. More accurate imaging, especially multiparametric magnetic resonance imaging can also provide information concerning staging and cancer volume, and thus may assist in the identification of patients with high-risk prostate cancer. A refined definition of non-metastatic high-risk prostate cancer is proposed. Within this high-risk cohort, patients with multiple high-risk criteria are especially at risk of prostate cancer-specific mortality.

AB - To identify criteria beyond Tumour-Node-Metastasis (TMN)-, prostate-specific antigen (PSA)- and Gleason score-based standard classifications to enhance the stratification of non-metastatic high-risk prostate cancer. A detailed search of the literature was performed using PubMed. The authors reviewed the literature and used a modified Delphi approach to identify relevant approaches to enhance standard classifications. Specific criteria for high-risk prostate cancer vary across guidelines and clinical trials, reflecting the differing perspectives concerning the definition of 'risk' between different specialities within the urology/radiation oncology community. In addition to the present classifications, evidence exists that the measure of cancer volume can provide additional prognostic value. More accurate imaging, especially multiparametric magnetic resonance imaging can also provide information concerning staging and cancer volume, and thus may assist in the identification of patients with high-risk prostate cancer. A refined definition of non-metastatic high-risk prostate cancer is proposed. Within this high-risk cohort, patients with multiple high-risk criteria are especially at risk of prostate cancer-specific mortality.

KW - high-risk prostate cancer

KW - prostate cancer

KW - risk stratification

UR - http://www.scopus.com/inward/record.url?scp=84892559227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892559227&partnerID=8YFLogxK

U2 - 10.1111/bju.12469

DO - 10.1111/bju.12469

M3 - Article

C2 - 24112742

AN - SCOPUS:84892559227

VL - 113

SP - 189

EP - 199

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 2

ER -